Periodic monitoring of hematologic & anti-anemia parameters (Hb, hematocrit, serum ferritin & transferrin saturation); w/held therapy in patients w/ evidence of Fe overload. Acute or chronic infection. Stop administration in patients w/ ongoing bacteremia. Hypotensive episodes if administered too rapidly. Allergic reactions, sometimes involving arthralgia. Avoid paravenous leakage. Avoid in patients w/ hepatic dysfunction where Fe overload is precipitating factor particularly porphyria cutanea tarda. Pregnancy & lactation. Not recommended in childn.